Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Impetigo
- Safety and Efficacy of Mupirocin Gel in Children With Impetigo
- Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo
- Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji
- Azithromycin - Ivermectin Mass Drug Administration for Skin Disease
- Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
- The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial
- A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo
- Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo
- Citriodiol® and Impetigo
- Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
- Safety and Efficacy of Topical NVC-422 Gel in Impetigo
- Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients
- EU PV for Retapamulin-Prescribing
- Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection
- Fucidin® Cream in the Treatment of Impetigo
- Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
- The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo
- Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)
- Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo
- Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment